Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
PROTHENA CORP PUBLIC LTD CO (PRTA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Prothena Reports Second Quarter 2023 Financial Results and Business Highlights"
02/23/2023 8-K Quarterly results
Docs: "Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights"
11/03/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
02/17/2022 8-K Quarterly results
Docs: "Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights"
11/04/2021 8-K Quarterly results
Docs: "Prothena Reports Third Quarter 2021 Financial Results and Business Highlights"
08/05/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
02/11/2021 8-K Quarterly results
11/04/2020 8-K Quarterly results
Docs: "Prothena Reports Third Quarter 2020 Financial Results and Provides"
08/06/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
02/12/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update • Net cash used in operating and investing activities was $9.2 million in the third quarter and $38.9 million for the first nine months of 2019; quarter-end cash and restricted cash position of $393.0 million provides funding to advance a diversified neuroscience pipeline"
08/06/2019 8-K Quarterly results
05/07/2019 8-K Quarterly results
Docs: "Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update • Net cash used in operating and investing activities was $17.6 million in the first quarter; quarter-end cash and restricted cash position of $414.2 million provides funding to advance neuroscience pipeline • Initiated cell line development of a lead candidate for preclinical tau program"
02/14/2019 8-K Quarterly results
Docs: "Prothena Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Financial Guidance and R&D Update"
11/06/2018 8-K Quarterly results
Docs: "Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update • Net cash used in operating and investing activities was $33.7 million in the third quarter and $7.5 million in the first nine months of 2018; quarter-end cash and restricted cash position of $455.6 million provides funding to advance neuroscience pipeline"
05/08/2018 8-K Quarterly results
Docs: "Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update"
11/07/2017 8-K Quarterly results
Docs: "Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update"
08/08/2017 8-K Quarterly results
05/09/2017 8-K Form 8-K - Current report
02/14/2017 8-K Form 8-K - Current report
11/01/2016 8-K Form 8-K - Current report
08/02/2016 8-K Form 8-K - Current report
05/03/2016 8-K Quarterly results
Docs: "Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update"
02/18/2016 8-K Quarterly results
Docs: "Prothena Reports Fourth Quarter and Full Year 2015 Financial Results; Provides Financial Guidance and R&D Update"
11/02/2015 8-K Quarterly results
Docs: "Prothena Reports Third Quarter 2015 Financial Results and Provides R&D Update"
08/04/2015 8-K Quarterly results
Docs: "Prothena Reports Second Quarter 2015 Financial Results and Provides R&D Update"
05/05/2015 8-K Quarterly results
Docs: "Prothena Reports First Quarter 2015 Financial Results and Provides R&D Update"
03/05/2015 8-K Quarterly results
Docs: "Prothena Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Financial Guidance and R&D Update"
11/03/2014 8-K Quarterly results
Docs: "Prothena Reports Third Quarter 2014 Financial Results and R&D Progress"
08/04/2014 8-K Quarterly results
Docs: "Prothena Reports Second Quarter 2014 Financial Results and R&D Progress"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy